EAACI Congress 2024
BackTPS83 - Mastocytosis and mast cells
Sunday 02 Jun, 12:00 PM -
13:00 PM Valencia, Spain
Poster Zone
Thematic Poster Session
1064-nm Q-switched Nd: YAG laser with low-level laser therapy inhibits mast cell activation
Accuracy of non-invasive diagnostics in hymenoptera venom allergy
Clinical Evaluation of Allergic Diseases in Pediatric Patients Diagnosed with Cutaneous Mastocytosis: A Retrospective Study
Healthcare Provider Perspectives on Management of European Patients with Systemic Mastocytosis
IL-4, TSLP, IL-31 cytokine profile in patients with cognitive disfunctions in systemic mastocytosis
Inhibition of Skin Mast Cell Degranulation by MRGPRX2 Small Molecule Antagonists
Investigation of Sleep Disorders by Polysomnography in Patients with Systemic Mastocytosis
Mastocytosis with skin involvement due to a 6bp insertion in frame in cKIT, responding to imatinib
Novel KIT Mutation, D816_N819delinsll, in a Patient with Systemic Mastocytosis: A Case Report
Presence of CD25+ mast cells in gastrointestinal biopsies of patients with systemic mastocytosis and gastrointestinal symptoms
Prevalence of Genetic Diamine Oxidase (DAO) deficiency in patients with systemic mastocytosis in Romania
SPOTLIGHT: A Phase 1b/2a, Dose Escalation Trial of Safety, Pharmacokinetic/Pharmacodynamic and Preliminary Clinical Activity of Briquilimab in Adult Patients with Chronic Inducible Urticaria (CIndU) Who Remain Symptomatic Despite Treatment with H1-Antihis
Targeting the JAK/STAT pathway with JAK2-selective inhibitors, but not JAK1-selective or JAK1/2 inhibitors, reduces proliferation and induces apoptosis in human neoplastic mast cells
Unprocessed bovine milk reduces IgE mediated mast cell degranulation and cytokine-induced IL-8 production by intestinal epithelial cells
